Low-grade B-cell lymphoma with coexpression of both CD5 and CD10 - A report of 3 cases

被引：0
|
作者：
Barekman, CL [1 ]
Aguilera, NSI
Abbondanzo, SL
机构：
[1] Walter Reed Army Med Ctr, Dept Pathol, Washington, DC 20307 USA
[2] Walter Reed Army Med Ctr, Dept Hematol, Washington, DC 20307 USA
[3] Armed Forces Inst Pathol, Dept Hematopathol, Washington, DC 20306 USA
来源：
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE | 2001年 / 125卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
The coexpression of CD5 and CD10 has previously been reported in cases of intermediate- and high-grade lymphomas and in precursor B cells in normal or regenerating bone marrow. We report 3 cases of low-grade B-cell lymphoma that were found to coexpress CD5 and CD10 at the time of initial diagnosis. The first case was classified as small lymphocytic lymphoma; the second as follicle center lymphoma, follicular grade 1; and the third as small B-cell lymphoma otherwise not specified. Currently, the clinical implication of the coexpression of CD5 and CD10 is not known. We describe this finding to highlight the difficulty that may he encountered in classifying lymphomas in cases where this coexpression is present.
引用
收藏
页码：951 / 953
页数：3
相关论文
共 50 条
  • [31] CD10 and BCL-6 expression in high-grade marginal zone B-cell lymphoma
    Higgins, JP
    Jones, CD
    Zehnder, JL
    Warnke, RA
    MODERN PATHOLOGY, 2001, 14 (01) : 166A - 166A
  • [32] NEUROLYMPHOMATOSIS, A RARE INDEX MANIFESTATION OF CD5/CD10 NEGATIVE MATURE B CELL LYMPHOMA PRESENTING AS SUBACUTE SENSORIMOTOR LAMBOSACRAL POLYRADICULONEUROPATHY
    Hrachova, Maya
    Xiao-Tang, Kong
    Zhao, Xiaohui
    NEURO-ONCOLOGY, 2019, 21 : 181 - 181
  • [33] CD10 and BCL-6 expression in high-grade marginal zone B-cell lymphoma
    Higgins, JP
    Jones, CD
    Zehnder, JL
    Warnke, RA
    LABORATORY INVESTIGATION, 2001, 81 (01) : 166A - 166A
  • [34] CD5(-) MANTLE CELL LYMPHOMA: A CASE REPORT
    Aslaner, M.
    Toka, B.
    Ergen, S.
    Tekin, I.
    Ertop, I.
    LEUKEMIA RESEARCH, 2014, 38 : S41 - S41
  • [35] Immunotherapy of B-Cell Lymphoma with an Engineered Bispecific Antibody Targeting CD19 and CD5
    Lttgau, Sandra
    Deppe, Dorothee
    Meyer, Saskia
    Fertig, Regina
    Panjideh, Hossein
    Lipp, Martin
    Schmetzer, Oliver
    Pezzutto, Antonio
    Breitling, Frank
    Moldenhauer, Gerhard
    ANTIBODIES, 2013, 2 (02): : 338 - 352
  • [36] CD5 ANTIGEN EXPRESSION IN LOW-GRADE B-CELL LYMPHOMAS OF MUCOSA-ASSOCIATED LYMPHOID-TISSUE (LGBL/MALT)
    COOK, P
    PUGH, WC
    LABORATORY INVESTIGATION, 1994, 70 (01) : A106 - A106
  • [37] Primary hepatic low-grade B-cell lymphoma: A case report
    Huti, E.
    Gunel, N.
    Berdica, L.
    EJC SUPPLEMENTS, 2010, 8 (04): : 13 - 14
  • [38] An unusual case of leukemic mantle cell lymphoma with a blastoid component showing loss of CD5 and aberrant expression of CD10
    Morice, WG
    Hodnefield, JM
    Kurtin, PJ
    Hanson, CA
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2004, 122 (01) : 122 - 127
  • [39] The clinical significance of CD10 antigen expression in diffuse large B-cell lymphoma
    Uherova, P
    Ross, CW
    Schnitzer, B
    Singleton, TP
    Finn, WG
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2001, 115 (04) : 582 - 588
  • [40] Monoclonal antibodies recognizing CD5, CD10 and CD23 in formalin-fixed, paraffin-embedded tissue: production and assessment of their value in the diagnosis of small B-cell lymphoma
    Watson, P
    Wood, KM
    Lodge, A
    McIntosh, GG
    Milton, I
    Piggott, NH
    Proctor, SJ
    Taylor, PR
    Smith, S
    Jack, F
    Bell, H
    Steward, M
    Anderson, JJ
    Horne, CHW
    Angus, B
    HISTOPATHOLOGY, 2000, 36 (02) : 145 - 150
12345